6.
Lynch 3rd J, Kajon A
. Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention. Semin Respir Crit Care Med. 2016; 37(4):586-602.
PMC: 7171713.
DOI: 10.1055/s-0036-1584923.
View
7.
Rowe W, Hartley J, HUEBNER R
. Additional serotypes of the APC virus group. Proc Soc Exp Biol Med. 1956; 91(2):260-2.
DOI: 10.3181/00379727-91-22231.
View
8.
Hograindleur M, Effantin G, Fenel D, Mas C, Lieber A, Schoehn G
. Binding Mechanism Elucidation of the Acute Respiratory Disease Causing Agent Adenovirus of Serotype 7 to Desmoglein-2. Viruses. 2020; 12(10).
PMC: 7599583.
DOI: 10.3390/v12101075.
View
9.
Williams C, Headd J, Moriarty N, Prisant M, Videau L, Deis L
. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2017; 27(1):293-315.
PMC: 5734394.
DOI: 10.1002/pro.3330.
View
10.
Kandiah E, Giraud T, De Maria Antolinos A, Dobias F, Effantin G, Flot D
. CM01: a facility for cryo-electron microscopy at the European Synchrotron. Acta Crystallogr D Struct Biol. 2019; 75(Pt 6):528-535.
PMC: 6580229.
DOI: 10.1107/S2059798319006880.
View
11.
Kimanius D, Forsberg B, Scheres S, Lindahl E
. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. Elife. 2016; 5.
PMC: 5310839.
DOI: 10.7554/eLife.18722.
View
12.
Ludford-Menting M, Thomas S, Crimeen B, Harris L, Loveland B, Bills M
. A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization. J Biol Chem. 2001; 277(6):4477-84.
DOI: 10.1074/jbc.M108479200.
View
13.
Garcia-Carbonero R, Salazar R, Duran I, Osman-Garcia I, Paz-Ares L, Bozada J
. Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection. J Immunother Cancer. 2017; 5(1):71.
PMC: 5604344.
DOI: 10.1186/s40425-017-0277-7.
View
14.
Segerman A, Atkinson J, Marttila M, Dennerquist V, Wadell G, Arnberg N
. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol. 2003; 77(17):9183-91.
PMC: 187375.
DOI: 10.1128/jvi.77.17.9183-9191.2003.
View
15.
Hemminki O, Diaconu I, Cerullo V, Pesonen S, Kanerva A, Joensuu T
. Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer. Mol Ther. 2012; 20(9):1821-1830.
PMC: 3437574.
DOI: 10.1038/mt.2012.115.
View
16.
Ravindranath N, Shuler C
. Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas. J Oral Pathol Med. 2006; 35(9):560-7.
DOI: 10.1111/j.1600-0714.2006.00466.x.
View
17.
Aricescu A, Lu W, Jones E
. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr. 2006; 62(Pt 10):1243-50.
DOI: 10.1107/S0907444906029799.
View
18.
Lopez-Gordo E, Doszpoly A, Duffy M, Coughlan L, Bradshaw A, White K
. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction in the Presence of Mouse Serum. J Virol. 2017; 91(12).
PMC: 5446653.
DOI: 10.1128/JVI.02487-16.
View
19.
Zhang K
. Gctf: Real-time CTF determination and correction. J Struct Biol. 2015; 193(1):1-12.
PMC: 4711343.
DOI: 10.1016/j.jsb.2015.11.003.
View
20.
Wang R, Song Y, Barad B, Cheng Y, Fraser J, DiMaio F
. Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta. Elife. 2016; 5.
PMC: 5115868.
DOI: 10.7554/eLife.17219.
View